The Association Between Maternal Progesterone Use During Pregnancy and Offspring Attention Deficit Hyperactivity Disorder Risk
Journal of Attention Disorders · 2026
DOI: 10.1177/10870547251381867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Attention Disorders, 2026. Verfasst von Elham Bidabadi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran. Hauptthemen laut MEDLINE: Progesterone, Attention Deficit Disorder with Hyperactivity, Prenatal Exposure Delayed Effects. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Objective
Previous animal studies have suggested a link between progesterone exposure and the development of attention deficit hyperactivity disorder (ADHD). This study clinically evaluated the effect of progesterone use during pregnancy on the risk of ADHD in children.
Methods
In this prospective case-control study, 97 children diagnosed with ADHD and 194 age- and sex-matched controls were included. Maternal progesterone use—via suppositories or injections—during pregnancy was assessed. Data were analyzed using SPSS.
Results
The mean age was slightly higher in the ADHD group, but not significantly. Male predominance was observed among ADHD cases, although not statistically significant. While neonatal hospitalization rates were similar, the duration was longer in the ADHD group ( p = .009). Cesarean delivery and lower maternal education levels were significantly more common in the ADHD group ( p = .004 and p = .013, respectively). No significant difference in overall progesterone use was found between ADHD and control groups (17.5% vs. 19.1%; p = .749). Injectable progesterone was used in 5.2% of ADHD cases and 10.8% of controls ( p = .130), and the timing of use across pregnancy trimesters did not differ significantly ( p = .493). Vaginal suppository use was also comparable (15.5% vs. 12.4%; p = .465). However, continuous progesterone use throughout all trimesters was more frequently reported among ADHD cases (20.0% vs. 4.2%), suggesting a possible association that needs further investigation.
Conclusion
Unlike findings from animal models, progesterone use during pregnancy does not appear to be associated with ADHD development. Still, prolonged exposure may warrant further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
- Reproductive Health Research Center, Department of Obstetrics & Gynecology, Guilan University of Medical Sciences, Rasht, Iran.
ORCID-Profile: Elham Bidabadi, Seyedeh Hajar Sharami, Seyyedeh Azade Hoseini Nouri, Masoumeh Parandavar, Afagh Hassanzadeh Rad
Zitieren
APA
Bidabadi, E., Sharami, S. H., Hoseini Nouri, S. A., Parandavar, M., & Hassanzadeh Rad, A. (2026). The Association Between Maternal Progesterone Use During Pregnancy and Offspring Attention Deficit Hyperactivity Disorder Risk. Journal of Attention Disorders. https://doi.org/10.1177/10870547251381867
Vancouver
Bidabadi E, Sharami SH, Hoseini Nouri SA, Parandavar M, Hassanzadeh Rad A. The Association Between Maternal Progesterone Use During Pregnancy and Offspring Attention Deficit Hyperactivity Disorder Risk. Journal of Attention Disorders. 2026. doi:10.1177/10870547251381867
BibTeX
@article{Bidabadi2026,
author = {Bidabadi, Elham and Sharami, Seyedeh Hajar and Hoseini Nouri, Seyyedeh Azade and Parandavar, Masoumeh and Hassanzadeh Rad, Afagh},
title = {The Association Between Maternal Progesterone Use During Pregnancy and Offspring Attention Deficit Hyperactivity Disorder Risk},
journal = {Journal of Attention Disorders},
year = {2026},
doi = {10.1177/10870547251381867}
}
EUVIMED